| Primary information |
|---|
| ID | antitb_1741, |
| Name | US 2012/0197004 |
| N-Terminal modification | FKAB-1Ga |
| C-Terminal Modification | G-GF-Tic-Oic-GK-Tic-Oic-GF-Tic-Oic-GK-Tic-KKKK |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | Tic = tetrahydroisoquinolinecarboxylic acid, Oic = Octahydroindolecarboxylic acid |
| Chirality | Linear |
| Nature | 20 |
| Source | L |
| Origin | Hydrophobic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium ranae |
| In Vitro/ In vivo | Mycobacterium ranae |
| Cell Line | MIC = 10 μM |
| Inhibition Concentration | Both |
| Sequence | 2012 |
| Cytotoxicity | RBC |
| In vivo Model | NA |
| Lethal Dose | 33.4 % hemolysis at 100 μM and 14.3 % at 25 μM |
| Immune Responce | Mice |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | None |
| Year of Publication | Anti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis) |
Tertiary Structure
(Technique) | Not Predicted), |